comparemela.com

Latest Breaking News On - Rare disease portfolio - Page 1 : comparemela.com

PM360 Announces 2023 Trailblazer Award Finalists

PM360 Announces 2023 Trailblazer Award Finalists
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Expanding Pipeline Leads to Name Change LQT Therapeutics Now Thryv Therapeutics

Expanding Pipeline Leads to Name Change LQT Therapeutics Now Thryv Therapeutics

Premier Pharmacy Services Adds KRYSTEXXA® (Pegloticase) to Rare Disease Portfolio

BALDWIN PARK, Calif. - January 25, 2022 - (Newswire.com) Access for KRYSTEXXA® (pegloticase) is now available for eligible patients for home infusion at Premier Pharmacy Services. KRYSTEXXA is a PEGylated uric acid-specific enzyme indicated for the treatment of chronic gout in adult patients.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.